Digitisation | April 10, 2026
Beacon raises $132M+ to bring AI-driven sleep diagnostics to masses
The device aims to bring precision neuroscience into clinical trials, accelerating drug development
The device aims to bring precision neuroscience into clinical trials, accelerating drug development
The dual expansion simplifies transcriptomics workflows by combining faster regional turnaround with easier sample logistics
Nature Medicine study delivers strongest real-world evidence yet for India’s indigenous rotavirus vaccine under UIP
Drugmaker taps 1 million retail touchpoints, quick commerce and modern trade to expand ingredient-led skincare franchise
Both ordinary resolutions sail through with over 99.6% votes in favour, strengthening leadership continuity at the drugmaker
API maker begins circulation of second and final call money notice for partly paid-up rights shares, completing the last leg of its 2024 fundraising cycle
Interchangeable biosimilars to Prolia and Xgeva target osteoporosis and cancer-related bone complications in a $5 billion U.S. market
The trial also demonstrated significant improvements across multiple secondary endpoints
Sharp increase in diabetes, hypertension and fatty liver in 30–50 age group
Recognition across subsidiaries and geographies highlights pharma major’s focus on inclusive culture, employee experience, and global workforce development
Subscribe To Our Newsletter & Stay Updated
